期刊文献+

溃疡性结肠炎患者外周血中MMP-2、MMP-9与肠黏膜通透性关系的临床研究 被引量:12

The relationship between the expression of matrix metalloproteinases and intestinal mucosal permeability in patients with ulcerative colitis
下载PDF
导出
摘要 目的探讨溃疡性结肠炎(UC)患者中基质金属蛋白酶(MMP)-2、MMP-9水平与肠黏膜通透性的临床关联,为UC的发病机制及治疗提供可靠的参考指标。方法采用ELISA法检测38例UC患者(UC组)和30例正常对照者(正常对照组)外周血中MMP-2、MMP-9水平;采用高效液相色谱示差法检测UC组和正常对照组口服乳果糖(L)和甘露醇(M)测试液后尿液中L、M含量,计算L/M比值。结果 UC组外周血中MMP-2、MMP-9水平显著高于正常对照组(P<0.05)。UC组外周血中MMP-2、MMP-9水平与UC疾病严重程度及病变范围呈一定相关性;UC组患者尿中L/M比值显著高于正常对照组(P<0.05),UC患者外周血中MMP-2、MMP-9水平与肠黏膜通透性改变有良好的相关性。结论活动期UC患者肠黏膜通透性增高,可能与外周血中MMP-2、MMP-9水平增高有关。 Objective To investigate the relationship between the expression of matrix metalloproteinases ( MMPs) and intestinal mucosal permeability in patients with ulcerative colitis. Methods 38 UC patients and 30 healthy controls were enrolled in this study, the levels of MMP-2 and MMP-9 in the serum were assessed by ELISA method. Detected the lactulose and mannitol in urine of 38 UC patients and 30 healthy people after they took orally the lactulose and mannitol test solution by HPLC-RI method and calculated the ratio of them. Results The serum levels of MMP-2 and MMP-9 in UC patients were significantly higher than that in healthy controls, which were correlated with the severity and extent of disease ( P 〈 0. 05 ). The lactulosel mannitol ratio in 38 U C patients was signifi- cantly higher than that in 30 control people. The serum levels of MMP-2 and MMP-9 in UC patients were correlated with the the change of intestinal mucosal permeability. Conclusion The serum levels of MMP-2 and MMP-9 in UC patients are significantly increased, which is correlated with the change of intestinal mucosal permeability.
出处 《安徽医科大学学报》 CAS 北大核心 2014年第4期495-498,共4页 Acta Universitatis Medicinalis Anhui
基金 安徽省自然科学基金(编号:09020103010)
关键词 基质金属蛋白酶-2 基质金属蛋白酶-9 肠黏膜通 透性 溃疡性结肠炎 MMP-2 MMP-9 ulcerative colitis intestinal mucosal permeability
  • 相关文献

参考文献4

二级参考文献46

  • 1贾乾斌,吴言涛,毛海香,王波涌,汤宇.脂肪乳剂对梗阻性黄疸病人术后肝功能及脂代谢的影响[J].中国临床营养杂志,1999,7(3):112-114. 被引量:1
  • 2秦环龙,吴肇汉.不同碳链脂肪乳剂对肝脏外科病人术后的影响[J].中国临床营养杂志,1999,7(3):129-132. 被引量:4
  • 3欧阳钦,Rakesh Tandon,KL Goh,潘国宗,KM Fock,Claudio Fiocchi,SK Lam,萧树东,张虎(翻译),梁红亮(翻译),王玉芳(翻译),欧阳钦(审校).亚太地区炎症性肠病处理共识意见(二)[J].胃肠病学,2006,11(5):301-305. 被引量:47
  • 4叶献词,吴正祥,王巧民.蛋白酶激活受体2在溃疡性结肠炎患者肠黏膜中的表达[J].安徽医科大学学报,2007,42(1):34-37. 被引量:7
  • 5Mankertz J,Schulzke J D.Altered permeability in inflammatory bowel disease:pathophysiology and clinical implications[J].Curr Opin Gastroenterol,2007,23 (4):379-83.
  • 6Miki K,Butler R,Moore D,et al.Rapid and simultaneous quantification of rhamnose,mannitol,and lactulose in urine by HPLC for estimating intestinal permeability in pediatric practice[J].Clinical Chemistry,1996,42(1):71 -5.
  • 7Olson T S,Reuter B K,Scott K G,et al.The primary defect in experimental ileitis originates from a nonhematopoietic source[J].J Exp Med,2006,203(3):541 -52.
  • 8Arrieta M C,Madsen K,Doyle J,et al.Reducing small intestinal permeability attenuates colitis in the IL-10 gene deficient mice[J].Gut,2009,58(1):41 -8.
  • 9Lok K H,Ng C H,Hung H G,et al.Correlation of serum biomarkers with clinical severity and mucosal inflammation in Chinese ulcerative colitis patients[J].J Dig Dis,2008,9(4):219 -24.
  • 10Osada T,Ohkusa T,Okayasu I,et al.Correlations among total colonoscopic findings,clinical symptoms,and laboratory markers in ulcerative colitis[J].J Gastroenterol Hepatol,2008,23 (2):262-7.

共引文献1071

同被引文献140

  • 1范玉晶,裴凤华,宋吉涛,刘冰熔.TNF-α、ⅠL-8在溃疡性结肠炎大鼠模型中的表达[J].中华结直肠疾病电子杂志,2014,3(2):24-25. 被引量:3
  • 2卢艺涛,高静,姚桂琴.溃疡性结肠炎患者相关细胞因子的实验性研究[J].现代预防医学,2005,32(7):735-736. 被引量:54
  • 3桑力轩,刘汉立,姜敏.溃疡性结肠炎发病机制研究进展[J].世界华人消化杂志,2007,15(20):2249-2254. 被引量:86
  • 4中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年,济南)[J].中华消化杂志,2007,27(8):545-550. 被引量:1023
  • 5王晓飞,周金影,金向群,代春红.麦芽的药理研究及临床应用[J].中成药,2007,29(11):1677-1679. 被引量:50
  • 6de Bruyn M, Arijs I,Wollants WJ, et al. Neutrophil Gelatinase B-as-sociated lipocalin and matrix metalloproteinase-9 complex as a surrogateserum marker of mucosal healing in ulcerative colitis [ J ]. InflammBowel Dis, 2014,20(7) : 1198-1207.
  • 7Meijer MJ, Mieremet-Ooms MA, van der Zon AM, et al. Increasedmucosal matrix metalloproteinase-1 ,-2,-3 and-9 activity in patients withinflammatory bowel disease and the relation with Crohn ’ s disease phe-notype [J]. Dig Liver Dis, 2007, 39(8) : 733-739.
  • 8Latella G,Rogler G,Bamias G,et al.Results of the 4th scientific workshop of the ECCO(I):pathophysiology of intestinal fibrosis in IBD〔J〕.J Crohns Colitis,2014;8(10):1147-65.
  • 9Kofla-Dlubacz A,Matusiewicz M,Krzystek-Korpacka M,et al.Correlation of MMP-3 and MMP-9 with Crohn's disease activity in children〔J〕.Dig Dis Sci,2012;57(3):706-12.
  • 10Diamanti A,Knafelz D,Panetta F,et al.Thalidomide as rescue therapy for acute severe ulcerative colitis〔J〕.Eur Rev Med Pharmacol Sci,2014;18(12):1690-3.

引证文献12

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部